BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20104)

  • 1. Effects of asparagine synthetase inhibitors on asparaginase resistant tumors.
    Uren JR; Chang PK; Handschumacher RE
    Biochem Pharmacol; 1977 Aug; 26(15):1405-10. PubMed ID: 20104
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethacrynic acid--an inhibitor of L-asparagine synthetase.
    Jayaram HN; Cooney DA; Milman HA; Homan ER; King WM; Cragoe EJ
    Biochem Pharmacol; 1975 Oct; 24(19):1787-92. PubMed ID: 9943
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitors of L-asparagine synthetase, in vitro.
    Cooney DA; Driscoll JS; Milman HA; Jayaram HN; Davis RD
    Cancer Treat Rep; 1976 Oct; 60(10):1493-557. PubMed ID: 14784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Don, conv and donv--I. Inhibition of L-asparagine synthetase in vitro.
    Jayaram HN; Cooney DA; Milman HA; Homan ER; Rosenbluth RJ
    Biochem Pharmacol; 1976 Jul; 25(14):1571-82. PubMed ID: 8046
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of L-asparagine synthetase by mineral cations.
    Milman HA; Cooney DA; Ward JM
    Toxicol Appl Pharmacol; 1979 Sep; 50(3):573-80. PubMed ID: 42170
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology of L-asparaginase and the effects of host and enzyme modification.
    Uren JR
    Cancer Treat Rep; 1981; 65 Suppl 4():47-55. PubMed ID: 6125260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-Asparagine synthetase in serum as a marker for neoplasia.
    Cooney DA; King VD; Cable RG; Taylor B; Wodinsky I
    Cancer Res; 1976 Sep; 36(9 pt.1):3238-45. PubMed ID: 10081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to l-asparaginase.
    Li BS; Gu LJ; Luo CY; Li WS; Jiang LM; Shen SH; Jiang H; Shen SH; Zhang B; Chen J; Xue HL; Tang JY
    Leukemia; 2006 Dec; 20(12):2199-201. PubMed ID: 17039232
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential inhibitors of L-asparagine biosynthesis. 4. Substituted sulfonamide and sulfonylhydrazide analogues of L-asparagine.
    Brynes S; Burckart GJ; Mokotoff M
    J Med Chem; 1978 Jan; 21(1):45-9. PubMed ID: 22754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulators of the metabolism of L-asparagine: a search for endogenous inhibitors.
    Cooney DA; Jones MT; Milman HA; Young DM; Jayaram HN
    Int J Biochem; 1980; 11(6):519-39. PubMed ID: 6103827
    [No Abstract]   [Full Text] [Related]  

  • 11. A radiometric method for the measurement of L-asparagine synthetase activity: comparison with available methods.
    Milman HA; Cooney DA; Applebee S
    Int J Biochem; 1978; 9(11):803-16. PubMed ID: 33075
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential antitumor agents via inhibitors of L-asparagine synthetase: substituted sulfonamides and sulfonyl hydrazides related to glutamine.
    Brynes S; Fiorina VJ; Cooney DA; Milman HA
    J Pharm Sci; 1978 Nov; 67(11):1550-3. PubMed ID: 30838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase.
    Kiriyama Y; Kubota M; Takimoto T; Kitoh T; Tanizawa A; Akiyama Y; Mikawa H
    Leukemia; 1989 Apr; 3(4):294-7. PubMed ID: 2564453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the antitumor effectiveness of E. coli and Erwinia asparaginases.
    Roberts J; Schmid FA; Old LJ; Stockert E
    Cancer Biochem Biophys; 1976 May; 1(4):175-8. PubMed ID: 788892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of an experimental study of the antitumor activity of 1-asparaginase from E. coli and Erw. carotovora].
    Terent'eva TG; Sokolov AB; Navashin SM
    Antibiotiki; 1977 Jan; 22(1):78-81. PubMed ID: 320935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Asparagine synthetase: a marker for metastases.
    Cable RG; King VD; Cooney DA
    Biochem Med; 1977 Feb; 17(1):54-66. PubMed ID: 14632
    [No Abstract]   [Full Text] [Related]  

  • 17. Asparaginyl-tRNA and resistance of murine leukaemias to L-asparaginase.
    Gallo RC; Longmore JL; Adamson RH
    Nature; 1970 Sep; 227(5263):1134-6. PubMed ID: 5451107
    [No Abstract]   [Full Text] [Related]  

  • 18. L-asparaginyl-tRNA synthetase and L-asparagine synthetase activities of L-asparaginase-sensitive and -resistant forms of the mouse Gardner lymphoma 6C3HED.
    Davies MR; Lambert LP; Marshall RD
    Clin Sci (Lond); 1979 Jan; 56(6):539-45. PubMed ID: 38936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
    Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
    Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some properties of L-asparagine synthetase of the L-asparaginase-resistant mouse lymphoma 6C3HED [proceedings].
    Davies MR; Marshall RD
    Biochem Soc Trans; 1979 Feb; 7(1):174-6. PubMed ID: 35419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.